Voriconazole Treatment for Less-Common, Emerging, or Refractory Fungal Infections von Perfect, John R., Marr, Kieren A., Walsh, Thomas J., Greenberg, Richard N., DuPont, Bertrand, de la Torre-Cisneros, Juliàn, Just-Nübling, Gudrun, Schlamm, Haran T, Lutsar, Irja, Espinel-Ingroff, Ana, Johnson, Elizabeth

Volltext

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial von Kullberg, BJ, Sobel, JD, Ruhnke, M, Pappas, PG, Viscoli, C, Rex, JH, Cleary, JD, Rubinstein, E, Church, LWP, Brown, JM, Schlamm, HT, Oborska, IT, Hilton, F, Hodges, MR

Volltext

Strategy of Following Voriconazole versus Amphotericin B Therapy with Other Licensed Antifungal Therapy for Primary Treatment of Invasive Aspergillosis: Impact of Other Therapies o... von Patterson, Thomas F., Boucher, Helen W., Herbrecht, Raoul, Denning, David W., Lortholary, Olivier, Ribaud, Patricia, Rubin, Robert H., Wingard, John R., DePauw, Ben, Schlamm, Haran T., Troke, Peter, Bennett, John E.

Volltext

Anidulafungin compared with fluconazole therapy in critically ill patients von Kett, DH, Shorr, AF, Reboli, AC, Reisman, AC, Biswas, P, Schlamm, HT

Volltext

Haemophilus influenzae pneumonia in young adults with AIDS, ARC, or risk of AIDS von Schlamm, Haran T., Yancovitz, Stanley R.

Volltext

Clinical Effectiveness of a Pancreatic Enzyme Supplement von Valerio, David, Whyte, Eric H.A., Schlamm, Haran T., Ruggiero, John A., Blackburn, George L.

Volltext